Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV003062513 | SCV003441258 | pathogenic | Kabuki syndrome | 2022-08-08 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Pro1485Leufs*21) in the KMT2D gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KMT2D are known to be pathogenic (PMID: 22126750). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Kabuki syndrome (PMID: 24633898). For these reasons, this variant has been classified as Pathogenic. |